Table 1. Characteristics of the trials included in the meta-analysis.
| References | Baseline comparability | Sample size | Outcome Measure | Duration |
|---|---|---|---|---|
| Deng K 2010 | Reported | 40 | SYM, ECG, hs- CRP | 14d |
| Hu S 2011 | Reported | 100 | SYM, ECG | 14d |
| Li HP 2011 | Reported | 102 | SYM, ECG | 14d |
| Liang TH 2010 | Reported | 220 | SYM, ECG | 15d |
| Lu YJ 2010 | Reported | 80 | SYM, ECG | 14d |
| Meng LC 2012 | Reported | 80 | SYM, ECG, hs-CRP, IL-6 | 14d |
| Peng DY 2011 | Reported | 62 | SYM, ECG, hemorheology | 14d |
| Shao ZB 2009 | Reported | 69 | SYM, ECG | 14d |
| Shi SH 2011 | Reported | 82 | SYM, ECG | 14d |
| Tan ZH 2009 | Reported | 149 | SYM, ECG | 14d |
| Xu XR 2006 | Reported | 80 | SYM, ECG | 14d |
| Yu HW 2001 | Reported | 68 | SYM, ECG, BP, HR, hemorheology | 15d |
| Zhang QM 2012 | Reported | 50 | SYM, ECG, HL, hemorheology | 14d |
| Zhang XD 2011 | Reported | 143 | SYM, ECG | 14d |
| Zhao JG 2010 | Reported | 60 | SYM, ECG | 14d |
| Zhou BX 2007 | Reported | 120 | SYM, ECG | 14d |
SYM: symptoms; ECG: electrocardiography; hs-CRP: high-sensitivity C-reactive protein; BP: blood pressure; HR: heart rate.